![Estrogen receptor beta enhances chemotherapy response of GBM cells by down regulating DNA damage response pathways | Scientific Reports Estrogen receptor beta enhances chemotherapy response of GBM cells by down regulating DNA damage response pathways | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-019-42313-8/MediaObjects/41598_2019_42313_Fig1_HTML.png)
Estrogen receptor beta enhances chemotherapy response of GBM cells by down regulating DNA damage response pathways | Scientific Reports
![The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019) The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)](https://erc.bioscientifica.com/view/journals/erc/26/6/images/full-ERC-19-0087fig1.jpeg)
The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)
![The Expanding Complexity of Estrogen Receptor Signaling in the Cardiovascular System | Circulation Research The Expanding Complexity of Estrogen Receptor Signaling in the Cardiovascular System | Circulation Research](https://www.ahajournals.org/cms/asset/c6e18cb5-6a98-4986-b7c3-ad684217c68f/994fig02.jpeg)
The Expanding Complexity of Estrogen Receptor Signaling in the Cardiovascular System | Circulation Research
![The interaction between ER and NFκB in resistance to endocrine therapy | Breast Cancer Research | Full Text The interaction between ER and NFκB in resistance to endocrine therapy | Breast Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3196/MediaObjects/13058_2012_3043_Fig5_HTML.jpg)
The interaction between ER and NFκB in resistance to endocrine therapy | Breast Cancer Research | Full Text
Selective Estrogen Receptor Degraders (SERDs): A Promising Strategy for Estrogen Receptor Positive Endocrine-Resistant Breast Cancer | Journal of Medicinal Chemistry
![ERα determines the chemo-resistant function of mutant p53 involving the switch between lincRNA-p21 and DDB2 expressions: Molecular Therapy - Nucleic Acids ERα determines the chemo-resistant function of mutant p53 involving the switch between lincRNA-p21 and DDB2 expressions: Molecular Therapy - Nucleic Acids](https://www.cell.com/cms/attachment/365485e8-30fe-4582-ba51-73aa0f51d428/fx1_lrg.jpg)
ERα determines the chemo-resistant function of mutant p53 involving the switch between lincRNA-p21 and DDB2 expressions: Molecular Therapy - Nucleic Acids
![Deregulated estrogen receptor signaling and DNA damage response in breast tumorigenesis - ScienceDirect Deregulated estrogen receptor signaling and DNA damage response in breast tumorigenesis - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0304419X20302018-ga1.jpg)
Deregulated estrogen receptor signaling and DNA damage response in breast tumorigenesis - ScienceDirect
![The interaction between ER and NFκB in resistance to endocrine therapy | Breast Cancer Research | Full Text The interaction between ER and NFκB in resistance to endocrine therapy | Breast Cancer Research | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fbcr3196/MediaObjects/13058_2012_3043_Fig1_HTML.jpg)
The interaction between ER and NFκB in resistance to endocrine therapy | Breast Cancer Research | Full Text
![The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019) The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)](https://erc.bioscientifica.com/view/journals/erc/26/6/images/full-ERC-19-0087fig3.jpeg)
The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)
![The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019) The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)](https://erc.bioscientifica.com/view/journals/erc/26/6/images/full-ERC-19-0087fig2.jpeg)
The NF-KB pathway and endocrine therapy resistance in breast cancer in: Endocrine-Related Cancer Volume 26 Issue 6 (2019)
![Cells | Free Full-Text | Cell-Type Targeted NF-kappaB Inhibition for the Treatment of Inflammatory Diseases | HTML Cells | Free Full-Text | Cell-Type Targeted NF-kappaB Inhibition for the Treatment of Inflammatory Diseases | HTML](https://www.mdpi.com/cells/cells-09-01627/article_deploy/html/images/cells-09-01627-g001.png)
Cells | Free Full-Text | Cell-Type Targeted NF-kappaB Inhibition for the Treatment of Inflammatory Diseases | HTML
![Cancers | Free Full-Text | NF-κB/Rel Transcription Factors in Pancreatic Cancer: Focusing on RelA, c-Rel, and RelB | HTML Cancers | Free Full-Text | NF-κB/Rel Transcription Factors in Pancreatic Cancer: Focusing on RelA, c-Rel, and RelB | HTML](https://www.mdpi.com/cancers/cancers-11-00937/article_deploy/html/images/cancers-11-00937-g001.png)